Methylene Blue (25mg) / Methylliberine (50mg) x 60 Tablets
• Composition and format
Methylene Blue (25mg) / Methylliberine (50 mg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 25 mg of methylene blue and 50 mg of methylliberine, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details active-component identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
Methylene Blue (25mg) / Methylliberine (50 mg) is evaluated in controlled in-vitro systems interrogating mitochondrial redox cycling, electron-transport-associated pathways, and neuroactive signaling models, including studies of monoamine- and adenosine-associated mechanisms under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This combination of methylene blue and methylliberine is characterized for use as a multi-analyte research tool in analytical and cell-based models examining redox modulation, cellular energy-related signaling, and neurochemical pathway mapping. In defined in-vitro environments, researchers employ the formulation to study electron-transfer dynamics, changes in cellular redox state, receptor- and transporter-level responses, second-messenger generation, and interaction networks between redox-active and neuroactive systems. Representative applications include assay development, comparative profiling of concentration-response relationships, time-course analyses, and mechanistic studies of mitochondrial and signaling-pathway behavior strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Methylene Blue (25mg) / Methylliberine (50mg) x 60 Tablets
Methylene Blue (25mg) / Methylliberine (50mg) x 60 Tablets
• Composition and format
Methylene Blue (25mg) / Methylliberine (50 mg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 25 mg of methylene blue and 50 mg of methylliberine, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details active-component identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
Methylene Blue (25mg) / Methylliberine (50 mg) is evaluated in controlled in-vitro systems interrogating mitochondrial redox cycling, electron-transport-associated pathways, and neuroactive signaling models, including studies of monoamine- and adenosine-associated mechanisms under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This combination of methylene blue and methylliberine is characterized for use as a multi-analyte research tool in analytical and cell-based models examining redox modulation, cellular energy-related signaling, and neurochemical pathway mapping. In defined in-vitro environments, researchers employ the formulation to study electron-transfer dynamics, changes in cellular redox state, receptor- and transporter-level responses, second-messenger generation, and interaction networks between redox-active and neuroactive systems. Representative applications include assay development, comparative profiling of concentration-response relationships, time-course analyses, and mechanistic studies of mitochondrial and signaling-pathway behavior strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
• Composition and format
Methylene Blue (25mg) / Methylliberine (50 mg) x 60 Tablets is a fixed-combination research formulation supplied as solid-format tablets for controlled laboratory workflows. Each tablet contains 25 mg of methylene blue and 50 mg of methylliberine, with 60 tablets per container. The batch-specific Certificate of Analysis (COA) details active-component identities, per-unit content, physical form, and relevant excipient information, supporting method-level reproducibility, mass-balance calculations, and documentation control in research environments.
• Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
• Intended research use
Methylene Blue (25mg) / Methylliberine (50 mg) is evaluated in controlled in-vitro systems interrogating mitochondrial redox cycling, electron-transport-associated pathways, and neuroactive signaling models, including studies of monoamine- and adenosine-associated mechanisms under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.
• Research characteristics and applications
This combination of methylene blue and methylliberine is characterized for use as a multi-analyte research tool in analytical and cell-based models examining redox modulation, cellular energy-related signaling, and neurochemical pathway mapping. In defined in-vitro environments, researchers employ the formulation to study electron-transfer dynamics, changes in cellular redox state, receptor- and transporter-level responses, second-messenger generation, and interaction networks between redox-active and neuroactive systems. Representative applications include assay development, comparative profiling of concentration-response relationships, time-course analyses, and mechanistic studies of mitochondrial and signaling-pathway behavior strictly within laboratory settings.
• Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Research Use Only (RUO) Statement
• For in-vitro research only
• Not for human or animal consumption
• Not for diagnostic or therapeutic use
